Clopidogrel Market Revolutionary Opportunities 2025 : Pfizer, Dr Reddy's, Apotex Corp
Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention.
View full press release